Physician

Iris Gin, MD

According to 2025 Medicare claims, Iris Gin, MD (NPI: 1588722680) practices dermatology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY - PACIFIC, P.C. (NPI: 1861121741; TIN: 77-0440158) and primary practice location at 95032-2056.

Gin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 471 traditional Medicare patients, billed 16,959 HCPCS/CPT codes, and received $1,075,093 in Medicare payments. The top billing code was G6001 (Ultrasonic guidance for placement of radiation therapy fields). Part D data shows 334 prescription claims across 149 beneficiaries totaling $39,670 in drug costs, led by Opzelura (Ruxolitinib Phosphate). Open Payments data shows 206 records totaling $7,865. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $64,897 to $1,075,093. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $15,870 and ending at $39,670. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$564K$1.1M2015 Medicare payment: $64,897 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $77,752 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $71,008 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $94,585 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $106,994 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $113,341 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $114,525 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $200,213 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,128,777 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,075,093 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015250990$64,897
20162581,210$77,752
20172451,116$71,008
20182761,227$94,585
20193305,097$106,994
20202964,638$113,341
20213223,272$114,525
20223657,366$200,213
202342212,708$1,128,777
202447116,959$1,075,093

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$48K2015 Drug cost: $15,870 (USD; Tot_Drug_Cst)2016 Drug cost: $15,155 (USD; Tot_Drug_Cst)2017 Drug cost: $9,075 (USD; Tot_Drug_Cst)2018 Drug cost: $7,964 (USD; Tot_Drug_Cst)2019 Drug cost: $12,221 (USD; Tot_Drug_Cst)2020 Drug cost: $11,704 (USD; Tot_Drug_Cst)2021 Drug cost: $7,601 (USD; Tot_Drug_Cst)2022 Drug cost: $9,659 (USD; Tot_Drug_Cst)2023 Drug cost: $48,025 (USD; Tot_Drug_Cst)2024 Drug cost: $39,670 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201557121$15,870
201675169$15,155
201760124$9,075
201861149$7,964
201995191$12,221
202092206$11,704
202199184$7,601
202297188$9,659
2023133285$48,025
2024149334$39,670

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G6001Ultrasonic guidance for placement of radiation therapy fields961,596$196
17110Destruction of skin growth, 1-14 growths163245$100
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more9797$83
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3961,263$81
17000Destruction of precancer skin growth, 1 growth98144$48

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OpzeluraRuxolitinib Phosphate13390$26,156
FluorouracilFluorouracil30891$2,553
ValacyclovirValacyclovir Hcl19687$1,269
Triamcinolone AcetonideTriamcinolone Acetonide14435$661
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc481,304$618

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.206$7,865ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Iris Gin, MD?

Tedicare shows public-source Medicare data for Iris Gin, MD (NPI 1588722680), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Iris Gin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Iris Gin, MD?

Iris Gin, MD is linked to FOREFRONT DERMATOLOGY - PACIFIC, P.C. (billing NPI 1861121741) in the available physician profile data.

Does Iris Gin, MD have Open Payments data?

Iris Gin, MD has 206 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.